Madrigal Pharmaceuticals (MDGL) Asset Utilization Ratio (2011 - 2026)
Madrigal Pharmaceuticals' (MDGL) quarterly Asset Utilization Ratio came in at 0.91 in Q1 2026, up 192.54% year-on-year from 0.31 in Q1 2025, and up 24.58% on a QoQ basis from 0.73 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 6 years of Asset Utilization Ratio data on file, last reported at 0.91 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 192.54% year-over-year to 0.91 in Q1 2026; TTM through Mar 2026 was 0.91, a 192.54% increase from a year earlier, with the FY2025 full-year figure at 0.83, up 288.97% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.91, up from 0.73 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for MDGL reached as high as 0.91 in Q1 2026 and fell as low as 0.01 in Q2 2024.
- Historically, Asset Utilization Ratio has averaged 0.42 across 3 years, with a median of 0.41 in 2025.
- Across the five-year window, Asset Utilization Ratio jumped 3719.66% in 2025 and soared 192.54% in 2026, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.17 in 2024, then surged by 329.27% to 0.73 in 2025, then rose by 24.58% to 0.91 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.91 in Q1 2026, 0.73 in Q4 2025, and 0.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - | 0.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.91 |
| Dec 31, 2025 | 0.73 |
| Sep 30, 2025 | 0.62 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.17 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.01 |
| Dec 31, 2013 | 0.00 |
| Sep 30, 2013 | 0.00 |
| Jun 30, 2013 | 0.01 |
| Sep 30, 2012 | 0.01 |
| Jun 30, 2012 | 0.04 |
| Mar 31, 2012 | 0.04 |
| Dec 31, 2011 | 0.07 |
| Sep 30, 2011 | 0.12 |